Chromatin state mapping pinpoints PAX3–FOXO1 (P3F) in active enhancers

Slides:



Advertisements
Similar presentations
Methods to read out regulatory functions
Advertisements

Regulomics II: Epigenetics and the histone code Jim Noonan GENE760.
ENCODE enhancers 12/13/2013 Yao Fu Gerstein lab. ‘Supervised’ enhancer prediction Yip et al., Genome Biology (2012) Get enhancer list away to genes DNase.
An Introduction to ENCODE Mark Reimers, VIPBG (borrowing heavily from John Stamatoyannopoulos and the ENCODE papers)
Supplementary Figure 1 Gene A1 st Gene B1 st Gene C1 st ~ Gene G1 st 2 nd ~ 19 th Gene H1 st 2 nd ~ 19 th Gene I1 st 2 nd ~ 19 th ~ 1 st 2 nd 19 th Gene.
Genomics 2015/16 Silvia del Burgo. + Same genome for all cells that arise from single fertilized egg, Identity?  Epigenomic signatures + Epigenomics:
Epigenetics Continued
Functional Elements in the Human Genome
Figure 1. Annotation and characterization of genomic target of p63 in mouse keratinocytes (MK) based on ChIP-Seq. (A) Scatterplot representing high degree.
Volume 5, Issue 3, Pages (March 2016)
Figure 1. Distinct chromatin regions isolated by the N-ChroP strategy
Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states by Thu-Hang Pham, Christopher.
Disentangling the Effects of Colocalizing Genomic Annotations to Functionally Prioritize Non-coding Variants within Complex-Trait Loci  Gosia Trynka,
High-Resolution Profiling of Histone Methylations in the Human Genome
Volume 63, Issue 1, Pages (July 2016)
Volume 51, Issue 3, Pages (August 2013)
Volume 23, Issue 7, Pages (May 2018)
OTX2 is associated with higher levels of activity when paired with NEUROD1 and arranged in clusters. OTX2 is associated with higher levels of activity.
Genome-Wide Analysis of PLT2 Binding to Target Genes.
3D Chromosome Regulatory Landscape of Human Pluripotent Cells
Lucas J.T. Kaaij, Robin H. van der Weide, René F. Ketting, Elzo de Wit 
Volume 63, Issue 2, Pages (July 2016)
Shinsuke Ohba, Xinjun He, Hironori Hojo, Andrew P. McMahon 
Nucleosome-Driven Transcription Factor Binding and Gene Regulation
Chromatin binding sites shared by pCREB1 and ERα are predominantly cAMP induced. Chromatin binding sites shared by pCREB1 and ERα are predominantly cAMP.
RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs by Mylène Gerritsen, Guoqiang Yi,
High-Resolution Profiling of Histone Methylations in the Human Genome
Volume 23, Issue 1, Pages 9-22 (January 2013)
Volume 62, Issue 1, Pages (April 2016)
Volume 17, Issue 6, Pages (November 2016)
Genome-wide analysis of p53 occupancy.
Srinivas Ramachandran, Kami Ahmad, Steven Henikoff  Molecular Cell 
Systematic mapping of functional enhancer-promoter connections with CRISPR interference by Charles P. Fulco, Mathias Munschauer, Rockwell Anyoha, Glen.
Volume 67, Issue 6, Pages e6 (September 2017)
STATs Shape the Active Enhancer Landscape of T Cell Populations
Volume 62, Issue 1, Pages (April 2016)
Human Promoters Are Intrinsically Directional
Genome-wide binding sites of OsMADS1 and the distribution of binding sites in different regions of annotated genes. Genome-wide binding sites of OsMADS1.
Evolution of Alu Elements toward Enhancers
Volume 10, Issue 10, Pages (October 2017)
Volume 17, Issue 11, Pages (December 2016)
Systematic mapping of functional enhancer–promoter connections with CRISPR interference by Charles P. Fulco, Mathias Munschauer, Rockwell Anyoha, Glen.
Volume 21, Issue 6, Pages e6 (December 2017)
Volume 66, Issue 4, Pages e4 (May 2017)
Volume 16, Issue 6, Pages (December 2012)
Volume 32, Issue 6, Pages (June 2010)
Anh Pham Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease.
Volume 6, Issue 4, Pages (April 2016)
Enhancer Malfunction in Cancer
Increased signal intensity and significant enrichment of transcription factor motifs is observed with DSG in breast tissue. Increased signal intensity.
ChIP-seq analyses in primary in prostate tissue.
STAT4 facilitates a permissive epigenetic landscape (H3K4me3) in activated NK cells. STAT4 facilitates a permissive epigenetic landscape (H3K4me3) in activated.
Fig. 3 Conserved genomic association of PRC1 activity in different leukemic cells. Conserved genomic association of PRC1 activity in different leukemic.
ChIP-seq for H3K4me and H3K27ac assigns potential enhancers to transcripts under control of HoxA9. ChIP-seq for H3K4me and H3K27ac assigns potential enhancers.
Kmt2b targets both bivalent and monovalent chromatin in GSCs
Volume 10, Issue 7, Pages (February 2015)
Volume 24, Issue 8, Pages e7 (August 2018)
Fig. 2 Dynamics of H3K4me3 in human early development.
Characteristics of a novel intronic enhancer human islet.
Volume 26, Issue 5, Pages (November 2014)
EZH2 overexpression establishes a unique and conserved super-enhancer–associated transcriptional landscape. EZH2 overexpression establishes a unique and.
Histone modification status at the Tβ4 promoter and at the protein level in the HuH7 sublines. Histone modification status at the Tβ4 promoter and at the.
Volume 17, Issue 11, Pages (December 2016)
HOXA9 and STAT5 co-occupy similar genomic regions and increase JAK/STAT signaling. HOXA9 and STAT5 co-occupy similar genomic regions and increase JAK/STAT.
BRD4 expression and genomic distribution in B-CLL.
Fig. 7. JQ1 represses the enhancer-promoter interaction of BRCA1.
Mutant TERT promoter displays active histone marks and distinct long-range interactions: A, cell lines that were used in the study with their origin and.
JQ1 selectively ablates PAX3–FOXO1-driven transcription and BRD4 interaction. JQ1 selectively ablates PAX3–FOXO1-driven transcription and BRD4 interaction.
Transcriptional and epigenetic landscapes of RMS cell lines and primary tumors. Transcriptional and epigenetic landscapes of RMS cell lines and primary.
Fig. 2 Combined transcriptome profiling, ChIP-seq, and ATAC-seq analysis identifies 14 highly plausible direct targets of Runx. Combined transcriptome.
Presentation transcript:

Chromatin state mapping pinpoints PAX3–FOXO1 (P3F) in active enhancers. Chromatin state mapping pinpoints PAX3–FOXO1 (P3F) in active enhancers. A, PAX3–FOXO1 peak distribution and heat maps of PAX3–FOXO1, H3K27ac, H3K4me1, and H3K4me2 at distal regulatory elements in PAX3–FOXO1-bearing cell line (RH4). The scatter plot is accompanied by a histogram showing the amounts of PAX3–FOXO1 in intronic, exonic, intergenic, or promoter-proximal sites. TSS, transcription start site. Rows are centered around PAX3–FOXO1 peaks and extended 4 kb in each direction, sorted by PAX3–FOXO1 signal strength. B, PAX3–FOXO1, H3K27ac, H3K27me3, and H3K4me3 signal at PAX3–FOXO1 peaks (left), genes nearest to PAX3–FOXO1 peaks (center), and Polycomb-repressed chromatin (right). Mean distance of PAX3–FOXO1 to its nearest genes (18 kb) is indicated. C, Chromatin states in FP-RMS cells (left) and abundance of PAX3–FOXO1 peaks per Gb of each state (right). States were discovered de novo using ChIP-seq data for all histone marks (plus, CTCF and RAD21) with the hidden Markov modeling algorithm chromHMM, which bins the genome into states by recurring patterns. Frequency corresponds to the probability of each mark being present in a given state. D, High-confidence PAX3–FOXO1 sites bound to enhancers recurrent (n = 1,107) in FP-RMS cell lines and tumors, some of which are shared with FN-RMS (n = 334) and/or myogenic cells and tissue (n = 446). Berkley E. Gryder et al. Cancer Discov 2017;7:884-899 ©2017 by American Association for Cancer Research